• DT-TRAP for More Specific Chemoproteomics

  2026-10-07

  The pre-proof study introduces dose- and temperature-optimized TRAP, or DT-TRAP, as a streamlined strategy for improving target recognition in chemical proteomics. Its central findings are that a simplified three-dose design can identify bona fide targets and that 4 °C incubation suppresses nonspecific interactions relative to higher temperatures, although broader validation remains necessary.

• Ionophore Toxicity in Animals: Key Findings

  2026-10-07

  Ekinci, Chłodowska, and Olejnik integrate clinical observations with molecular toxicology to explain how polyether ionophores can disrupt cation balance, oxidative phosphorylation, and muscle-cell function in animals. The review also highlights species, age, dose, and tiamulin–ionophore interactions, while emphasizing that important mechanistic and translational questions remain unresolved.

• EZ Cap Cy5 Firefly Luciferase mRNA: Evidence

  2026-10-06

  EZ Cap Cy5 Firefly Luciferase mRNA combines firefly luciferase activity with covalent Cy5 fluorescence for dual-readout mRNA delivery studies. The product dossier supports its design rationale, while peer-reviewed evidence from a related lipoplex study provides context rather than direct validation of the R1010 product.

• EZ Cap™ Firefly Luciferase mRNA: Evidence and Context

  2026-10-06

  A source-grounded overview of Cap1 firefly luciferase mRNA as a bioluminescent reporter, its conceptual uses in delivery and gene regulation research, and the limits of extrapolating from supplier information and pregnant-mouse LNP studies.

• Spleen-Targeted Neoantigen mRNA Vaccine in HCC

  2026-10-05

  Lin et al. report a spleen-targeted neoantigen mRNA vaccine that produced strong antitumor activity in orthotopic hepatocellular carcinoma models and was associated with improved survival. The study further identifies ISG15-positive CD8-positive T cells, GZMA–F2R signaling, and tertiary lymphoid structure formation as components of a proposed immune mechanism, while leaving important translational questions unresolved.

• Verteporfin (CL 318952): Evidence and Research Context

  2026-10-05

  Verteporfin, also known as CL 318952, is an established photosensitizer for photodynamic therapy in ocular neovascularization. Product-level evidence also describes light-independent effects on p62-mediated autophagy, but the supplied senolytic study did not validate Verteporfin as one of its reported senolytic compounds.

• AmpliFold Capture-and-Release for Sensitive LFAs

  2026-10-04

  The ChemRxiv preprint introduces AmpliFold, a capture-and-release concept designed to reduce the dependence of lateral flow assays on rapid test-line binding kinetics. In a HER2 model, the authors report up to 16-fold improvement in limit of detection and a 12-fold sensitivity enhancement with large gold nanoparticles, while emphasizing that the work remains a proof of concept rather than peer-reviewed validation.

• Marein and ABCG2: Restoring Cancer Drug Sensitivity

  2026-10-03

  A 2024 Biochemical Pharmacology study identifies marein, a flavonoid from Coreopsis tinctoria Nutt, as a competitive inhibitor of the ABCG2 drug efflux transporter. The work links marein activity to the conserved F439 residue and reports increased sensitivity of ABCG2-expressing cancer cells to several transporter-substrate chemotherapeutics, while leaving clinical translation and broader transporter selectivity unresolved.

• CTOP for μ-Opioid Receptor Signaling Studies

  2026-10-02

  CTOP provides a reversible, receptor-level way to test whether μ-opioid receptor activity drives opioid signaling, mechanical hypersensitivity, or analgesic tolerance. This guide translates recent brain–spinal circuit findings into practical assay workflows while clarifying where pharmacological blockade complements—but cannot replace—cell-specific methods.

• Promethazine HCl: Macrophage Assay Workflows

  2026-10-01

  Promethazine HCl combines H1 receptor antagonism with a practical platform for studying ROS, autophagy, lysosomal activity, and intracellular antibacterial defense. This guide translates phenothiazine research into reproducible workflows for inflammation research, histaminergic signaling, and mechanism-focused cell assays.

• MARF Folding Architecture Boosts mRNA Expression

  2026-10-01

  The reference study introduces metal-ion-assisted RNA folding (MARF), a strategy that reshapes global mRNA architecture before lipid nanoparticle delivery. Its results indicate that tertiary RNA structure can alter nanoparticle mechanics, intracellular processing, mRNA retention, and protein output, with up to 7.3-fold higher expression and durable Pcsk9 editing after intravenous administration.

• Microfluidic Peptide/RNA Complexes for Pulmonary Delivery

  2026-09-30

  This 2025 study shows that microfluidic mixing can produce reproducible LAH4-L1 and PEG12KL4 peptide/RNA complexes that remain suitable for vibrating-mesh nebulisation. The formulations generated respirable aerosols while retaining RNA binding and in vitro transfection performance, supporting further development of peptide-based pulmonary delivery systems.

• Annexin V-Cy5 for Smarter Apoptosis Detection

  2026-09-30

  Apoptosis detection is most informative when separated from lysosomal dysfunction, phagocytic stress, and reversible cellular adaptation. This thought-leadership guide connects mechanistic findings from mestranol-exposed zebrafish microglia with a practical Annexin V-Cy5 workflow for translational neuroimmunology research.

• 8-Chloroadenosine for RNA Regulation Workflows

  2026-09-29

  Use 8-Chloroadenosine as a controlled transcriptional perturbation tool for separating RNA synthesis effects from post-transcriptional stability mechanisms. This workflow connects nucleoside analog treatment with the RP3-340N1.2–IL-6 axis in NSCLC while emphasizing formulation, time-course design, and interpretation limits.

• Cyanine 5-dCTP for DNA Labeling Workflows

  2026-09-29

  Cyanine 5-dCTP adds a bright red fluorescent handle to enzymatically produced DNA, supporting PCR labeling, probe construction, nucleic acid detection, and imaging. This guide pairs practical optimization with the ordered DNA-framework strategy reported for higher-efficiency enzymatic oligonucleotide synthesis.

752 records 1/51 page Next 12345 下5页 Last page